Back to Stakeholders

Independent Academic Research Groups

KGK Science Inc.

Canada

2 Trials

KGK Science Inc. is a Canadian contract research organization (CRO) based in London, Ontario, specializing in clinical trial execution across natural health products, novel therapeutics, and medical devices. The company has served as a trial management partner on psilocybin studies for treatment-resistant PTSD and behavioral and cognitive symptoms in adults with Fragile X Syndrome.

Quick Facts

Type: Other
HQ: Canada
Website: Visit

Collaborated Trials

2

Temporarily not availableII

An Investigation of Psilocybin on Behavioural and Cognitive Symptoms of Adults With Fragile X Syndrome

Start Date: March 28, 2023
Compounds: Psilocybin

Unknown statusII

Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder

Start Date: February 18, 2022
Compounds: Psilocybin